1-13 of 13
Camelia Iancu-Rubin, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results of a Phase II Study of PD-1 Inhibition in Advanced Myeloproliferative Neoplasms

Gabriela S. Hobbs, MD, Cansu Cimen Bozkus, Martha Wadleigh, MD, Lonette Sandy, Mikaela Doughtery, Kathryn Johnson, Gillian Sanchez, Julia E. Foster, NP, Molly Macrae, Tina T. Som, RN, Michal Bar-Natan, MD, Richard M. Stone, MD, Erin Moshier, MS, Camelia Iancu-Rubin, PhD, John Mascarenhas, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–15.
https://doi.org/10.1182/blood-2020-137294
Published: 2020
Journal Articles

Harnessing a Novel Dyrk1a-Ablim2-MKL1 Regulatory Module in Megakaryocyte Morphogenesis to Enable Scalable Platelet "Pharming"

Kamaleldin E Elagib, PhDMBBS, Ashton Brock, PhD, Goar Mosoyan, Cara Clementelli, Lorrie L Delehanty, BS, Alexandra Pacheco-Benichou, Corinne Fruit, Thierry Besson, PhD, Stephen Morris, MD, Koji Eto, MD, Camelia Iancu-Rubin, PhD, Adam N Goldfarb, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3250.
https://doi.org/10.1182/blood-2019-129049
Published: 2019
Journal Articles

Modeling Calreticulin-Mutant Myeloproliferative Neoplasms with Isogenic Induced Pluripotent Stem Cells

Wei Wang, PhD, Tiansu Wang, PhD, Andriana G. Kotini, PhD, Camelia Iancu-Rubin, PhD, Ronald Hoffman, MD, Eirini P. Papapetrou, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4319.
https://doi.org/10.1182/blood-2018-99-111512
Published: 2018
Journal Articles

AVID200, a Potent Trap for TGF-β Ligands Inhibits TGF-β1 Signaling in Human Myelofibrosis

Lilian Varricchio, PhD, John Mascarenhas, MD, Anna Rita Migliaccio, PhD, Maureen O'Connor-McCourt, PhD, Gilles Tremblay, Jean-François Denis, Camelia Iancu-Rubin, PhD, Ronald Hoffman, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1791.
https://doi.org/10.1182/blood-2018-99-116474
Published: 2018
Journal Articles

Infusion of a Cryopreservable Human Megakaryocyte-Biased Cell Product Results in Sustained Platelet Reconstitution In Vivo

Ami Patel, MS, Manisha Kintali, MS, Gohar Mosoyan, Ronald Hoffman, MD, Camelia Iancu-Rubin, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 117.
https://doi.org/10.1182/blood-2018-99-118682
Published: 2018
Journal Articles

Immune Checkpoint Blockade Enhances Mutated Calreticulin-Induced T Cell Immunity in Myeloproliferative Neoplasms

Cansu Cimen Bozkus, PhD, John P Finnigan, MDPhDStudent, John Mascarenhas, MD, Ronald Hoffman, MD, Nina Bhardwaj, MD PhD, Camelia Iancu-Rubin, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 384.
https://doi.org/10.1182/blood.V130.Suppl_1.384.384
Published: 2017
Journal Articles

Preclinical Development of a Cryopreservable Megakaryocyte Cell Product from Cord Blood Derived Hematopoietic Stem Cells

Helen Fong, PhD, Goar Mosoyan, Ami Patel, MS, Ronald Hoffman, MD, Jay Tong, MD, Camelia Iancu-Rubin, PhD
Journal: Blood
Blood (2016) 128 (22): 3859.
https://doi.org/10.1182/blood.V128.22.3859.3859
Published: 2016
Journal Articles

An IGF2BP3-Cdk9 Pathway Governs the Human Fetal-Adult Megakaryocyte Transition

Kamaleldin E Elagib, MBBS, PhD, Chih-Huan Lu, BS, Goar Mosoyan, Ewelina Zasadzińska, MS, Daniel R Foltz, PhD, Peter Balogh, Els Verhoeyen, Miriam Sansó, PhD, Robert P Fisher, MD PhD, Camelia Iancu-Rubin, PhD, Adam N Goldfarb, MD
Journal: Blood
Blood (2016) 128 (22): 886.
https://doi.org/10.1182/blood.V128.22.886.886
Published: 2016
Journal Articles

Preclinical Development of a Cord Blood (CB)-Derived Hematopoietic Stem Cell (HSC) Product for Allogeneic Transplantation in Patients with Hematological Malignancies

Camelia Iancu-Rubin, PhD, Helen Fong, PhD, Goar Mosoyan, Ami Patel, MS, Rachel Sabado, PhD, Meseck Marcia, MS, Erin Moshier, MS, Umut Ozbek, PhD, Alla Keyzner, MD, Nina Bhardwaj, MD PhD, Ian K. McNiece, PhD, Jay Tong, MD, Ronald Hoffman, MD
Journal: Blood
Blood (2016) 128 (22): 818.
https://doi.org/10.1182/blood.V128.22.818.818
Published: 2016
Journal Articles

The JAK2 V617F Mutation Disrupts the Regulatory Activity Exerted By Calreticulin on the Glucocorticoid Receptor in Erythroid Cells

Mario Falchi, PhD, Lilian Varricchio, PhD, Fabrizio Martelli, PhD, Francesca Masiello, Orietta Piccioni, Agostino Tafuri, MD, Gabriella Girelli, Camelia Iancu-Rubin, PhD, Ronald Hoffman, MD, Anna Rita Migliaccio, PhD
Journal: Blood
Blood (2015) 126 (23): 5216.
https://doi.org/10.1182/blood.V126.23.5216.5216
Published: 2015
Journal Articles

An Inhibitor of TGF-β Promotes Proliferation of Normal but Not MPN Hematopoietic Cells and Is a Candidate Therapeutic Agent for the Treatment of MPN Patients Carrying JAK2 V617F or Calr pQ365fs Mutations

Anna Rita Migliaccio, PhD, Camelia Iancu-Rubin, PhD, Rona Singer Weinberg, PhD, Ronald Hoffman, MD, Amylou Constance Dueck, PhD, John O. Mascarenhas, MD MS
Journal: Blood
Blood (2015) 126 (23): 4089.
https://doi.org/10.1182/blood.V126.23.4089.4089
Published: 2015
Journal Articles

Imetelstat (GRN163L), a Telomerase Inhibitor Selectively Affects Malignant Megakaryopoiesis in Myeloproliferative Neoplasms (MPN)

Camelia Iancu-Rubin, PhD, Goar Mosoyan, Craig C Parker, Kevin Eng, PhD, Ronald Hoffman, MD
Journal: Blood
Blood (2014) 124 (21): 4582.
https://doi.org/10.1182/blood.V124.21.4582.4582
Published: 2014
Journal Articles

The Role of Microtubule Regulatory Protein Stathmin (STMN1) in Megakaryopoiesis.

Camelia Iancu-Rubin, PhD, Joseph Tripodi, Vesna Najfeld, Ph.D., George F. Atweh, MD
Journal: Blood
Blood (2009) 114 (22): 4591.
https://doi.org/10.1182/blood.V114.22.4591.4591
Published: 2009